391 related articles for article (PubMed ID: 27314466)
1. Update on clinical trials in systemic lupus erythematosus.
Narain S; Furie R
Curr Opin Rheumatol; 2016 Sep; 28(5):477-87. PubMed ID: 27314466
[TBL] [Abstract][Full Text] [Related]
2. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
Furie R; Toder K; Zapantis E
Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553
[TBL] [Abstract][Full Text] [Related]
3. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
Harvey PR; Gordon C
BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
[TBL] [Abstract][Full Text] [Related]
4. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
Yap DYH; Chan TM
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
[TBL] [Abstract][Full Text] [Related]
5. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
Steiger S; Ehreiser L; Anders J; Anders HJ
Front Immunol; 2022; 13():999704. PubMed ID: 36211360
[TBL] [Abstract][Full Text] [Related]
6. Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells?
Kalunian KC
Lupus; 2016 Sep; 25(10):1097-101. PubMed ID: 27497254
[TBL] [Abstract][Full Text] [Related]
7. Lupus nephritis: the evolving role of novel therapeutics.
Rovin BH; Parikh SV
Am J Kidney Dis; 2014 Apr; 63(4):677-90. PubMed ID: 24411715
[TBL] [Abstract][Full Text] [Related]
8. New and future therapies: Changes in the therapeutic armamentarium for SLE.
Askanase A; Khalili L; Tang W; Mertz P; Scherlinger M; Sebbag E; Chasset F; Felten R; Arnaud L
Best Pract Res Clin Rheumatol; 2023 Dec; 37(4):101865. PubMed ID: 37633826
[TBL] [Abstract][Full Text] [Related]
9. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
Hachulla É
Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S241-4. PubMed ID: 22202645
[TBL] [Abstract][Full Text] [Related]
10. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
Trindade VC; Carneiro-Sampaio M; Bonfa E; Silva CA
Paediatr Drugs; 2021 Jul; 23(4):331-347. PubMed ID: 34244988
[TBL] [Abstract][Full Text] [Related]
11. New biologic therapy for systemic lupus erythematosus.
Ding HJ; Gordon C
Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
[TBL] [Abstract][Full Text] [Related]
12. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Merrill JT; Wallace DJ; Petri M; Kirou KA; Yao Y; White WI; Robbie G; Levin R; Berney SM; Chindalore V; Olsen N; Richman L; Le C; Jallal B; White B;
Ann Rheum Dis; 2011 Nov; 70(11):1905-13. PubMed ID: 21798883
[TBL] [Abstract][Full Text] [Related]
13. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
[TBL] [Abstract][Full Text] [Related]
14. From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?
Parodis I; Houssiau FA
Ann Rheum Dis; 2022 Jan; 81(1):15-19. PubMed ID: 34521616
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
16. Overview of pathophysiology and treatment of human lupus nephritis.
Trotter K; Clark MR; Liarski VM
Curr Opin Rheumatol; 2016 Sep; 28(5):460-7. PubMed ID: 27341623
[TBL] [Abstract][Full Text] [Related]
17. Towards new avenues in the management of lupus glomerulonephritis.
Mok CC
Nat Rev Rheumatol; 2016 Apr; 12(4):221-34. PubMed ID: 26729459
[TBL] [Abstract][Full Text] [Related]
18. The use of belimumab in three cases of refractory lupus nephritis.
Malaweera A; Dayan S; Pellicano R; Hoi A; Kitching AR; Kent JR
Intern Med J; 2023 Oct; 53(10):1901-1906. PubMed ID: 37859540
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
Fattah Z; Isenberg DA
Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
[TBL] [Abstract][Full Text] [Related]
20. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
